Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
about
Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.EGF receptor ligands: recent advancesEGFR oligomerization organizes kinase-active dimers into competent signalling platformsRegulation of oligomeric organization of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor observed by spatial intensity distribution analysisA structural perspective on the regulation of the epidermal growth factor receptor.Ligand regulation of a constitutively dimeric EGF receptor.Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion.Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling ProteinsEmerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocationActivation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.Predicting ligand-dependent tumors from multi-dimensional signaling features.Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells.A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.Quantifying the Interaction between EGFR Dimers and Grb2 in Live Cells.Significance of epidermal growth factor receptor signaling for acquisition of meiotic and developmental competence in mammalian oocytes.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.In Silico Evaluation of Variable pH on the Binding of Epidermal Growth Factor Receptor Ectodomain to its Ligand Through Molecular Dynamics Simulation in Tumors.Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.A threshold model for receptor tyrosine kinase signaling specificity and cell fate determination.
P2860
Q27691330-888EF8A3-308E-4DEB-BC3E-9AB78F789BEEQ28066531-C092733F-6197-4718-9559-934190B332B3Q30827493-9C0D5F8C-F11A-4C52-8C87-9D9B5B3DDE2BQ35590759-6CB6BA9B-DA9B-4C74-A2F9-0E64B6F0F909Q35674768-5A690AF2-E375-4033-B245-491DF6D3EB5EQ35733874-FC6F26FF-9EC2-4D3D-B188-22C2DFB26A62Q36171317-F4E756C6-9851-41D4-967F-27278B42BD9BQ36674591-CACB4D21-BE50-4E13-BBCA-D9004DFC9A60Q36687542-B581C79B-2B21-4ED9-83A2-17341985F33FQ38287552-F1FE56B1-A0A1-4828-9B26-9DC96039B297Q38755432-05E280EE-CFAD-44F0-AD40-DF7338B40B3CQ39346046-4AC7EDFB-FE6D-41D4-8501-CDE01499A4B0Q39393617-7C71BCB9-4FE3-4AEC-84A9-2B5210205E94Q41701603-BB98E3BF-DFF9-455D-BD56-8589A1555D45Q42177413-2F69DA0F-CD10-428B-BDD0-BE34CCF70488Q47583813-11B46965-CD93-4336-8EEB-CB4A6E6D74B0Q47598173-0607C62D-8852-46C2-9F3C-E980F0C97F45Q47680913-395FB3ED-E25C-42D5-AFAA-8FBE8FB6AA64Q47892855-1B67DDC9-E487-4477-AFCF-84F9945D31D6Q48511028-A4657D01-2B4E-4C91-AB37-E7448A432857Q49887925-55AD626D-7A8E-41E2-9FEF-4F265661A907Q50156659-E71B98AC-303A-4B18-887A-15A6283F8831Q50963822-16676D5A-D2A2-4B0E-A2DF-A3F82C05F09BQ52593090-C1CC238E-5F98-47D7-BAF4-8FD32F286BCEQ55440500-59B68762-71BD-412D-88BA-305FB4EFA49E
P2860
Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Different epidermal growth fac ...... mer and heterodimer formation.
@ast
Different epidermal growth fac ...... mer and heterodimer formation.
@en
Different epidermal growth factor
@nl
type
label
Different epidermal growth fac ...... mer and heterodimer formation.
@ast
Different epidermal growth fac ...... mer and heterodimer formation.
@en
Different epidermal growth factor
@nl
prefLabel
Different epidermal growth fac ...... mer and heterodimer formation.
@ast
Different epidermal growth fac ...... mer and heterodimer formation.
@en
Different epidermal growth factor
@nl
P2860
P356
P1476
Different epidermal growth fac ...... mer and heterodimer formation.
@en
P2093
Jennifer L Macdonald-Obermann
Linda J Pike
P2860
P304
26178-26188
P356
10.1074/JBC.M114.586826
P407
P577
2014-08-01T00:00:00Z